Insulin 287
Insuman (insulin 287) is a protein pharmaceutical. Insulin 287 was first approved as Insuman on 1997-02-21. It has been approved in Europe to treat diabetes mellitus.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| esika extreme moisturizing spf 16 | OTC monograph final | 2013-12-20 |
| lantus solostar | Biologic Licensing Application | 2023-06-06 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
2168 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 72 | 54 | 262 | 260 | 235 | 875 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 152 | 88 | 124 | 90 | 243 | 675 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 23 | 21 | 35 | 29 | 45 | 143 |
| Healthy volunteers/patients | — | 87 | 2 | 1 | 2 | 1 | 93 | ||
| Hyperglycemia | D006943 | HP_0003074 | R73.9 | 6 | 8 | 12 | 29 | 28 | 80 |
| Insulin resistance | D007333 | EFO_0002614 | 7 | 3 | 1 | 1 | 24 | 35 | |
| Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | 6 | 11 | 6 | 14 | 34 |
| Hypoglycemia | D007003 | HP_0001943 | E16.2 | 3 | 1 | 1 | 5 | 15 | 24 |
| Critical illness | D016638 | — | 3 | 2 | 1 | 5 | 10 | ||
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 4 | 1 | 2 | 2 | 9 |
Show 49 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 6 | — | 2 | — | 19 | 27 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | 9 | 1 | — | 1 | 11 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 2 | 7 | — | 3 | 10 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 2 | 3 | — | 4 | 8 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | 1 | 4 | — | 2 | 8 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | — | 5 | — | — | 6 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | 1 | — | 1 | — | 3 | 5 |
| Diabetes complications | D048909 | — | 3 | 4 | — | 1 | 5 | ||
| Sepsis | D018805 | A41.9 | — | 2 | 2 | — | 2 | 5 | |
| Hypogonadism | D007006 | E23.0 | 2 | 1 | 1 | — | 1 | 4 |
Show 26 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | G31.84 | 1 | 9 | — | — | 3 | 13 | |
| Hyperinsulinism | D006946 | HP_0000842 | E16.1 | 3 | 1 | — | — | 4 | 8 |
| Delirium | D003693 | R41.0 | 1 | 2 | — | — | 2 | 4 | |
| Exercise | D015444 | EFO_0000483 | — | 1 | — | — | 2 | 3 | |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 3 | — | — | — | 3 |
| Inflammation | D007249 | — | 1 | — | — | 1 | 2 | ||
| Pain | D010146 | EFO_0003843 | R52 | — | 1 | — | — | 1 | 2 |
| Premature birth | D047928 | EFO_0003917 | O60 | — | 2 | — | — | — | 2 |
| Multiple system atrophy | D019578 | — | 1 | — | — | 1 | 2 | ||
| Wounds and injuries | D014947 | T14.8 | 2 | 2 | — | — | — | 2 |
Show 18 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | 1 | — | — | — | 3 | 4 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | — | — | — | 2 | 3 |
| Carpal tunnel syndrome | D002349 | EFO_0004143 | G56.0 | 1 | — | — | — | 1 | 2 |
| Glaucoma | D005901 | EFO_0000516 | H40 | 2 | — | — | — | — | 2 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | 1 | — | — | — | 1 | 2 |
| Heart valve diseases | D006349 | EFO_0009551 | I08 | 1 | — | — | — | 1 | 2 |
| Intracranial aneurysm | D002532 | EFO_0003870 | I67.1 | 1 | — | — | — | 1 | 2 |
| Neoplasms | D009369 | C80 | 1 | — | — | — | 1 | 2 | |
| Down syndrome | D004314 | EFO_0001064 | Q90 | 1 | — | — | — | — | 1 |
| Aging | D000375 | GO_0007568 | R41.81 | 1 | — | — | — | — | 1 |
Show 10 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | — | — | — | 2 | 2 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | 2 | 2 | |
| Fetal macrosomia | D005320 | — | — | — | — | 2 | 2 | ||
| Orthostatic hypotension | D007024 | I95.1 | — | — | — | — | 2 | 2 | |
| Infertility | D007246 | EFO_0000545 | — | — | — | — | 2 | 2 | |
| Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | — | 2 | 2 |
| Pediatric obesity | D063766 | — | — | — | — | 2 | 2 | ||
| Therapeutic equivalency | D013810 | — | — | — | — | 2 | 2 | ||
| Artificial pancreas | D019397 | — | — | — | — | 2 | 2 | ||
| Spinal cord injuries | D013119 | EFO_1001919 | — | — | — | — | 2 | 2 |
Show 67 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | INSULIN 287 |
| INN | insulin icodec |
| Description | Insuman (insulin 287) is a protein pharmaceutical. Insulin 287 was first approved as Insuman on 1997-02-21. It has been approved in Europe to treat diabetes mellitus. |
| Classification | Protein |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4594581 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | P7YU3ED05N (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Insulin - Amphastar Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Insulin - Novo Nordisk
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 749,311 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
162,492 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more